SEC Filings
State Street Holds 5.5% Of Accenture Without Seeking To Influence Its Control
The passive stake covered 33,523,019 shares as of September 30, against a recovery in Accenture's stock.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
SEC Filings
The passive stake covered 33,523,019 shares as of September 30, against a recovery in Accenture's stock.
SEC Filings
The passive holding totals 7,650,889 shares, while Acadia awaits a ruling on protection for its NUPLAZID capsule formulation.
SEC Filings
The position covered 13,675,348 shares as of September 30, against the backdrop of ADMA's recent rally.
SEC Filings
The September position accompanies stronger cash generation and lower debt, while Albemarle faces pressure from lithium prices.
Earnings
Plaquemines helped lift operating results, while a $1.4 billion interest-rate swap gain figured in shareholder profit.
SEC Filings
The passive holding comes as Allegion expands its Americas business and expects 9.5–10.5% total revenue growth in 2026.
SEC Filings
The aircraft-parts maker expects 14% sales growth at the midpoint of its fiscal 2027 forecast.
SEC Filings
The passive holding covered 1,614,059 shares as of September 30, before the chip supplier's recent earnings-driven rally.
SEC Filings
The September 30 holding covered 16.3 million shares; Allogene released initial autoimmune-treatment trial results Monday.
SEC Filings
The 837,797-share position came with the coal producer facing a wider quarterly loss and higher expected sales costs.
Earnings
The lottery company kept its cash forecast intact excluding the Italy Lotto payment, while lowering expected capital spending.
SEC Filings
The September 30 position came into view Tuesday, while Altimmune plans a December FDA meeting on its alcohol-use-disorder program.